The relationship between risperidone plasma levels and dopamine D2 occupancy:: A positron emission tomographic study

被引:24
|
作者
Remington, G [1 ]
Kapur, S
Zipursky, R
机构
[1] Univ Toronto, Clarke Inst Psychiat, Schizophrenia Program, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Clarke Inst Psychiat, PET Ctr, Toronto, ON M5T 1R8, Canada
关键词
D O I
10.1097/00004714-199802000-00014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:82 / 83
页数:2
相关论文
共 50 条
  • [31] Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine:: theoretical implications
    Frankle, WG
    Gil, R
    Hackett, E
    Mawlawi, O
    Zea-Ponce, Y
    Zhu, Z
    Kochan, LD
    Cangiano, C
    Slifstein, M
    Gorman, JM
    Laruelle, M
    Abi-Dargham, A
    PSYCHOPHARMACOLOGY, 2004, 175 (04) : 473 - 480
  • [32] Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications
    W. G. Frankle
    R. Gil
    E. Hackett
    O. Mawlawi
    Y. Zea-Ponce
    Z. Zhu
    L. D. Kochan
    C. Cangiano
    M. Slifstein
    J. M. Gorman
    M. Laruelle
    A. Abi-Dargham
    Psychopharmacology, 2004, 175 : 473 - 480
  • [33] Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels
    Knable, MB
    Heinz, A
    Raedler, T
    Weinberger, DR
    PSYCHIATRY RESEARCH-NEUROIMAGING, 1997, 75 (02) : 91 - 101
  • [34] CHARACTERIZING THE RELATIONSHIP BETWEEN DOPAMINE D2 RECEPTOR OCCUPANCY AND PLASMA LEVELS OF HALOPERIDOL IN NON-HUMAN PRIMATES USING [18F]-FALLYPRIDE
    Rajagovindan, R.
    Wang, J.
    Tovcimak, A.
    Voorbach, M.
    Reuter, D.
    Giamis, A.
    Basso, A.
    Jacobson, P.
    Beaver, J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 664 - 664
  • [35] The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients
    Xing, Qinghe
    Qian, Xueqing
    Li, Huafang
    Wong, Shiming
    Wu, Shengnan
    Feng, Guoyin
    Duan, Shiwei
    Xu, Mingqing
    Gao, Rui
    Qin, Wei
    Gao, Jianjun
    Meng, Junwei
    He, Lin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05): : 631 - 637
  • [36] Main interactions of dopamine and risperidone with the dopamine D2 receptor
    Martinez, Ana
    Garcia-Gutierrez, Ponciano
    Zubillaga, Rafael A.
    Garza, Jorge
    Vargas, Rubicelia
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2021, 23 (26) : 14224 - 14230
  • [37] A positron emission tomography study of quetiapine in schizophrenia -: A preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy
    Kapur, S
    Zipursky, R
    Jones, C
    Shammi, CS
    Remington, G
    Seeman, P
    ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (06) : 553 - 559
  • [38] Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: A cross-sectional study
    Mizuno, Yuya
    Bies, Robert R.
    Remington, Gary
    Mamo, David C.
    Suzuki, Takefumi
    Pollock, Bruce G.
    Tsuboi, Takashi
    Watanabe, Koichiro
    Mimura, Masaru
    Uchida, Hiroyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 37 (01): : 182 - 187
  • [39] Bifeprunox:: Dopamine D2 receptor occupancy
    Devries, M
    Grahnen, A
    Bergström, M
    Långström, B
    Olsen, CK
    Brennum, LT
    Kreilgaard, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 243S - 244S
  • [40] Bifeprunox: Relationship between antipsychotic potential, EPS liability and dopamine D2 receptor occupancy in rats
    Hertel, P
    Brennum, L
    Helboe, L
    Olsen, CK
    Kreilgard, M
    Marquis, K
    Svensson, T
    Herremans, AHJ
    Hesselink, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S256 - S256